Boill Healthcare Holdings Limited (1246) AI Stock Analysis

• Market Cap: HK$28.52M
• Dividend Yield: N/A
• Average Volume (3M): 0.00
• Price to Earnings (P/E): ―
• Beta (1Y): -0.13
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: HK
• Employees: 26
• Sector: Real Estate
• Sector Strength: 73
• Industry: Real Estate - Development
• EPS (TTM): -0.09
• Shares Outstanding: 1,358,000,000
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 0
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.09
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 29 Underperform
• Price Target: ―

Boill Healthcare Holdings Limited faces major financial challenges, including declining revenues, negative profitability, high leverage, and zero cash flow generation, leading to a low financial performance score. The technical analysis suggests the stock is oversold, but there is no significant positive momentum. Valuation is hampered by persistent losses and a lack of investor returns. Overall, these factors result in a low stock score, indicating significant risks and challenges for the company.

Boill Healthcare Holdings Limited Business Overview & Revenue Model

Company Description

Boill Healthcare Holdings Limited (1246) is a company engaged in the healthcare and property development sectors. It primarily focuses on providing healthcare services and developing properties that cater to the healthcare industry. The company operates healthcare facilities and is involved in the development and management of healthcare-related properties.

How the Company Makes Money

Boill Healthcare Holdings Limited generates revenue through two main streams: healthcare services and property development. In the healthcare sector, the company earns income by operating healthcare facilities, which may include hospitals, clinics, or specialized care centers, where it provides medical services to patients. In the property development sector, the company develops and manages properties specifically designed for the healthcare industry, such as medical office buildings or hospital complexes. Revenue in this segment comes from property sales, leasing, and management fees. Partnerships with healthcare providers and real estate stakeholders significantly contribute to the company's earnings by enhancing service offerings and expanding its property portfolio.

Boill Healthcare Holdings Limited Financial Statement Overview

Summary

Boill Healthcare Holdings Limited is experiencing severe financial difficulties across all major financial statement areas. The company is struggling with declining revenues, negative profitability, high leverage, and a lack of cash flow generation. These factors collectively indicate significant financial instability and a need for strategic turnaround efforts to address these challenges and restore financial health.

Income Statement

The company has faced significant challenges in maintaining revenue and profitability. Revenue declined significantly from the previous year by 18.08%, and net income remains negative, indicating persistent losses. The gross profit margin is low at 3.69%, and both EBIT and EBITDA margins are negative, reflecting operational inefficiencies and potential cost management issues.

Balance Sheet

The balance sheet indicates high financial risk, with a negative equity position of -332.84 million, resulting in a Debt-to-Equity ratio that cannot be calculated conventionally but signifies high leverage. The company shows a negative Return on Equity due to ongoing losses, and the equity ratio is negative, reflecting more liabilities than assets.

Cash Flow

The company reports zero operating and free cash flow, which raises concerns about its ability to generate cash internally. This indicates potential liquidity issues, especially with no positive cash flows from operations to support business activities or reduce debt.

Breakdown
Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
285.20M	348.27M	1.00B	216.71M	106.35M
	Gross Profit
10.52M	-810.00K	106.85M	18.97M	10.79M
	EBIT
-37.02M	-186.59M	70.79M	-52.48M	-44.17M
	EBITDA
-36.80M	-180.22M	66.08M	-37.34M	-105.69M
	Net Income Common Stockholders
-118.64M	-428.25M	-517.80M	-142.49M	-189.43M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.08M	79.06M	93.55M	151.72M	98.91M
	Total Assets
1.30B	2.42B	3.49B	3.77B	2.18B
	Total Debt
842.17M	1.17B	1.57B	825.70M	961.94M
	Net Debt
841.71M	1.09B	1.47B	676.16M	866.28M
	Total Liabilities
1.63B	2.41B	3.24B	2.82B	1.29B
	Stockholders Equity
-332.84M	-135.58M	-11.54M	465.62M	407.21M
Cash Flow		Free Cash Flow
0.00	29.75M	-128.39M	-232.34M	-36.96M
	Operating Cash Flow
0.00	29.75M	-128.34M	-232.15M	-31.82M
	Investing Cash Flow
0.00	408.46M	-575.82M	50.16M	-17.13M
	Financing Cash Flow
0.00	-452.39M	645.67M	230.92M	79.33M

Boill Healthcare Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1246, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and above the 200-day MA of 0.02, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 38.61 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1246.

Boill Healthcare Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1681	78 Outperform	€9.54B	9.53	23.28%	5.24%	12.70%	9.91%
1110	70 Outperform	HK$351.77M	7.42	6.61%	5.46%	-3.59%	4.81%
Sector *	61 Neutral	$2.85B	10.99	0.40%	6.10%	5.75%	-21.23%
8139	57 Neutral	HK$85.49M	38.27	1.08%	―	17.93%	-48.93%
3886	50 Neutral	HK$1.56B	―	-6.55%	0.52%	0.04%	-4.88%
3869	48 Neutral	HK$594.23M	―	-10.78%	―	-0.95%	-128.35%
1246	29 Underperform	HK$28.52M	―		―	―	―